Medicines Optimisation Service
Medicines Optimisation Service – General Practice
1. Service Aims
The Medicines Optimisation Service aims to ensure the safe, effective, and evidence-based use of medicines across general practice, supporting both clinicians and patients in achieving the best possible health outcomes. The service seeks to:
- Improve the quality and safety of prescribing.
- Reduce unwarranted variation in medicines use.
- Optimise cost-effectiveness and minimise waste.
- Enhance patient understanding, adherence, and shared decision-making.
- Contribute to the sustainability and efficiency of primary care services.
2. Service Objectives
- Undertake structured medication reviews for patients with complex needs, polypharmacy, or long-term conditions.
- Identify and manage high-risk prescribing and medicines-related safety issues.
- Support deprescribing and medicines reconciliation, particularly post-discharge or following care transitions.
- Provide clinical advice and decision support to prescribers in line with NICE, NHS England, and local formulary guidance.
- Deliver education and training sessions for practice teams to strengthen prescribing governance.
- Engage with patients to promote self-management, understanding of their treatment, and adherence strategies.
3. Key Service Components
- Clinical Medication Reviews: Focused on high-priority cohorts such as frail elderly patients, those with multimorbidity, or patients on multiple medicines.
- Prescribing Support: Audits, feedback, and recommendations aligned to evidence-based guidelines.
- Cost-Effectiveness Initiatives: Identification of opportunities for switches to clinically appropriate and cost-effective alternatives.
- Patient Engagement: Structured discussions to support shared decision-making and improve medicines adherence.
- System Collaboration: Close working with PCNs, community pharmacists, secondary care, and wider healthcare teams to ensure seamless medicines use across care pathways.
4. Outcomes and Benefits
- Improved patient safety through reduction of medicines-related harm.
- Increased patient satisfaction and empowerment in managing their own care.
- Reduction in inappropriate polypharmacy and high-risk prescribing.
- Demonstrable savings and efficiencies in prescribing budgets.
- Strengthened governance and assurance for practices and PCNs.
